4Remme WJ. Beta blockers or angiotensin-converting enzyme inhibitor angiotensin recepter blocker : what should be first? [J]. Cardiol Clin,2007,25(4) :581-594.
4[2]Bourassa MG.Angiotensin II inhibition and prevention of atrial fibrillation and stroke[J].J Am Coll Cardiol,2005,45(5):720-721.
5[3]Pedersen OD,Bagger H,Kober L,et al.Trandolapril reduces the incidence of artrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction[J].Circulation,1999,100(4):376-380.
6[5]Madrid AH,Martin IM,Cervantes CE,et al.Prevention of recurrence in patients with lone artrial fibrillation:the dose-dependent effect of angiotensin II receptor blockers[J].J Renin Angiotensin AldosteroneSyst,2004,5(3):114-120.
7[6]Madrid AH,Martin IM,Cervantes CE,et al.Prevention of recurrence in patients with lone artrial fibrillation:the dose-dependent effect of angiotensin II recep tor blockers[J].J Renin Angiotensin Aldosterone Syst,2004,5:114-120.
8[7]Maggioni AP,Latini R,Carson PE,et al.Valsartan reduces the incidence of artrial fibrillation in patients with heart failure:results from the Valsartan Heart Failure Trail(Val -HeFT)[J].Am Heart J,2005,149(3):548-557.
9[8].Pedersen OD,Bagger H,Kober L,et al.Trandolapril reduces the incidence of artrial fibrillation after acute myocardial infarction in Patients with left ventricular dysfunction[J].Circulation,1999,100(4):376-380.
10Morillo CA,Klein GJ,Jones DL,et al.Chronic rapid pacing.Structural,functional and electrophysiological characteristics of a new model of sustained atrial fibrillation[J].Circulation,1995,91:1588-1595.
2Bahn RS,Tch HB,Cooper DS,et al.Hyperthyroidism andother causes of thyrotoxinosis:management guidelines of the American Thyroid Association and American Asmeiation of Clinical Endocrinologists[J].Endoer Proact,2011,17(3):457.
